Project Number 5R01AG057598-04 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Development of Attenuated Furoxans as Novel Therapies for Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator SCHIEFER, ISAAC THOMAS Principal Investigator First Name ISAAC Principal Investigator Last Name SCHIEFER Awardee Organization UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-16-041: DRUG DISCOVERY FOR NERVOUS SYSTEM DISORDERS (R01) FY Overall Cost $386,250 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
